Related Experiment Videos
C-reactive protein in acute renal failure.
N A Harrison1, R G Masterton, J M Bateman
1Renal Unit, Princess Mary's Royal Air Force Hospital Halton, Aylesbury, Buckinghamshire, UK.
Summary
C-reactive protein (CRP) aids in diagnosing infections in acute renal failure patients. Daily CRP testing using plasma is recommended for early infection detection in these critically ill individuals.
Area of Science:
- Clinical Chemistry
- Nephrology
- Infectious Diseases
Background:
- Infection is a primary cause of mortality in critically ill patients with acute renal failure.
- Early and accurate diagnosis of infection is challenging in this patient population.
- C-reactive protein (CRP) is a potential biomarker for infection detection.
Observation:
- C-reactive protein (CRP) can be reliably measured in plasma, circumventing issues associated with serum microclots in heparinized patients.
- Plasma CRP levels remain stable during hemodialysis, making it suitable for patients undergoing renal replacement therapy.
- Data from 20 patients with acute renal failure illustrate the utility of CRP in identifying infections.
Findings:
- C-reactive protein (CRP) assay is effective for diagnosing infections in patients with acute renal failure.
- Plasma is a suitable matrix for CRP measurement, offering advantages over serum.
- CRP levels are not affected by hemodialysis.
Implications:
- Daily monitoring of C-reactive protein (CRP) can significantly improve the early detection of infections in acute renal failure patients.
- Implementing routine CRP testing can aid clinicians in timely and appropriate management of infections.
- This approach may lead to improved patient outcomes and reduced mortality in this vulnerable group.